California Legislature · 2023-2024 Regular Session
Chaptered
ACR 21
California Kidney Day
Author:
Akilah Weber Pierson
(D-AD79)
Show 76 co-authors
Dawn Addis
(D-AD30)
Cecilia Aguiar-Curry
(D-AD04)
Juan Alanis
(R-AD22)
David Alvarez
(D-AD80)
Joaquin Arambula
(D-AD31)
Jasmeet Bains
(D-AD35)
Rebecca Bauer-Kahan
(D-AD16)
Steve Bennett
(D-AD38)
Marc Berman
(D-AD23)
Blanca Rubio
(D-AD48)
Tasha Boerner
(D-AD77)
Mia Bonta
(D-AD18)
Isaac Bryan
(D-AD55)
Lisa Calderon
(D-AD56)
Sabrina Cervantes
(D-AD58)
Phillip Chen
(R-AD59)
Damon Connolly
(D-AD12)
Laurie Davies
(R-AD74)
Diane Dixon
(R-AD72)
Bill Essayli
(R-AD63)
Heath Flora
(R-AD09)
Laura Friedman
(D-AD44)
Jesse Gabriel
(D-AD46)
Eduardo Garcia
(D-AD36)
Mike Gipson
(D-AD65)
Timothy Grayson
(D-AD15)
Matt Haney
(D-AD17)
Gregg Hart
(D-AD37)
Chris Holden
(D-AD41)
Josh Hoover
(R-AD07)
Jacqui Irwin
(D-AD42)
Corey Jackson
(D-AD60)
Jim Patterson
(R-AD08)
Joe Patterson
(R-AD05)
Reginald Byron Jones-Sawyer
(D-AD57)
Juan Carrillo
(D-AD39)
Ash Kalra
(D-AD25)
Tom Lackey
(R-AD34)
Alex Lee
(D-AD24)
Evan Low
(D-AD26)
Josh Lowenthal
(D-AD69)
Luz Rivas
(D-AD43)
Brian Maienschein
(D-AD76)
Devon Mathis
(R-AD33)
Kevin McCarty
(D-AD06)
Tina McKinnor
(D-AD61)
Megan Dahle
(R-AD01)
Mike Fong
(D-AD49)
Liz Ortega
(D-AD20)
Blanca Pacheco
(D-AD64)
Diane Papan
(D-AD21)
Gail Pellerin
(D-AD28)
Cottie Petrie-Norris
(D-AD73)
Sharon Quirk-Silva
(D-AD67)
James Ramos
(D-AD45)
Anthony Rendon
(D-AD62)
Eloise Gómez Reyes
(D-AD50)
Robert Rivas
(D-AD29)
Freddie Rodriguez
(D-AD53)
Kate Sanchez
(R-AD71)
Miguel Santiago
(D-AD54)
Pilar Schiavo
(D-AD40)
Esmeralda Soria
(D-AD27)
Stephanie Nguyen
(D-AD10)
Tri Ta
(R-AD70)
Philip Ting
(D-AD19)
Avelino Valencia
(D-AD68)
Carlos Villapudua
(D-AD13)
Vince Fong
(R-AD32)
Marie Waldron
(R-AD75)
Greg Wallis
(R-AD47)
Christopher Ward
(D-AD78)
Buffy Wicks
(D-AD14)
Lori Wilson
(D-AD11)
Jim Wood
(D-AD02)
Rick Chavez Zbur
(D-AD51)
Latest action:
Chaptered
(Apr 19, 2023)
Chapter 27, Statutes of 2023
Version history
Action history
-
Feb 17, 2023 Introduced. To print. Assembly
-
Feb 18, 2023 From printer. Assembly
-
Feb 23, 2023 Referred to Com. on RLS. Assembly
-
Mar 2, 2023 From committee: Be adopted. To Consent Calendar. (Ayes 13. Noes 0.) (March 2). Assembly
-
Mar 9, 2023 Adopted and to Senate. (Ayes 75. Noes 0. Page 586.) Assembly
-
Mar 9, 2023 Coauthors revised. Assembly
-
Mar 13, 2023 In Senate. To Com. on RLS. Senate
-
Mar 22, 2023 From committee: Ordered to third reading. Senate
-
Mar 28, 2023 Ordered to special consent calendar. Senate
-
Mar 30, 2023 Adopted and to Assembly. (Ayes 35. Noes 0. Page 589.) Senate
-
Mar 30, 2023 In Assembly. Ordered to Engrossing and Enrolling. Assembly
-
Apr 19, 2023 Enrolled and filed with the Secretary of State at 3 p.m. Secretary of State
-
Apr 19, 2023 Chaptered by Secretary of State - Res. Chapter 27, Statutes of 2023. Secretary of State
Votes recorded
2 votes
Mar 30, 2023 · Senate Floor
Special Consent ACR21 Weber et al.
Tally
35
·
0
·
5
PASS
Democrat
28/0/3
Republican
7/0/2
Other
0/0/0
Aye
(35)
Benjamin Allen
(D-SD24)
Bob Archuleta
(D-SD30)
Angelique Ashby
(D-SD08)
Toni Atkins
(D-SD39)
Josh Becker
(D-SD13)
Catherine Blakespear
(D-SD38)
Steven Bradford
(D-SD35)
Anna Caballero
(D-SD14)
Dave Cortese
(D-SD15)
Bill Dodd
(D-SD03)
Maria Elena Durazo
(D-SD26)
Susan Talamantes Eggman
(D-SD05)
Steven Glazer
(D-SD07)
Lena Gonzalez
(D-SD33)
Melissa Hurtado
(D-SD16)
Monique Limón
(D-SD19)
Mike McGuire
(D-SD02)
Caroline Menjivar
(D-SD20)
Dave Min
(D-SD37)
Josh Newman
(D-SD29)
Steve Padilla
(D-SD18)
Anthony Portantino
(D-SD25)
Richard Roth
(D-SD31)
Susan Rubio
(D-SD22)
Nancy Skinner
(D-SD09)
Lola Smallwood-Cuevas
(D-SD28)
Thomas Umberg
(D-SD34)
Scott Wiener
(D-SD11)
Marie Alvarado-Gil
(R-SD04)
Brian Dahle
(R-SD01)
Brian Jones
(R-SD40)
Roger Niello
(R-SD06)
Rosilicie Ochoa Bogh
(R-SD23)
Kelly Seyarto
(R-SD32)
Scott Wilk
(R-SD21)
Abstain / Other
(5)
John Laird
(D-SD17)
Henry Stern
(D-SD27)
Aisha Wahab
(D-SD10)
Shannon Grove
(R-SD12)
Janet Nguyen
(R-SD36)
Mar 9, 2023 · Assembly Floor
ACR 21 Weber Consent Calendar Second Day Regular Session
Tally
75
·
0
·
5
PASS
Democrat
58/0/4
Republican
17/0/1
Other
0/0/0
Aye
(75)
Dawn Addis
(D-AD30)
Cecilia Aguiar-Curry
(D-AD04)
David Alvarez
(D-AD80)
Joaquin Arambula
(D-AD31)
Jasmeet Bains
(D-AD35)
Rebecca Bauer-Kahan
(D-AD16)
Steve Bennett
(D-AD38)
Marc Berman
(D-AD23)
Blanca Rubio
(D-AD48)
Tasha Boerner
(D-AD77)
Mia Bonta
(D-AD18)
Isaac Bryan
(D-AD55)
Lisa Calderon
(D-AD56)
Sabrina Cervantes
(D-AD58)
Damon Connolly
(D-AD12)
Laura Friedman
(D-AD44)
Jesse Gabriel
(D-AD46)
Eduardo Garcia
(D-AD36)
Mike Gipson
(D-AD65)
Timothy Grayson
(D-AD15)
Matt Haney
(D-AD17)
Gregg Hart
(D-AD37)
Chris Holden
(D-AD41)
Corey Jackson
(D-AD60)
Reginald Byron Jones-Sawyer
(D-AD57)
Juan Carrillo
(D-AD39)
Ash Kalra
(D-AD25)
Alex Lee
(D-AD24)
Evan Low
(D-AD26)
Josh Lowenthal
(D-AD69)
Luz Rivas
(D-AD43)
Brian Maienschein
(D-AD76)
Kevin McCarty
(D-AD06)
Mike Fong
(D-AD49)
Al Muratsuchi
(D-AD66)
Liz Ortega
(D-AD20)
Blanca Pacheco
(D-AD64)
Diane Papan
(D-AD21)
Gail Pellerin
(D-AD28)
Cottie Petrie-Norris
(D-AD73)
Sharon Quirk-Silva
(D-AD67)
James Ramos
(D-AD45)
Anthony Rendon
(D-AD62)
Eloise Gómez Reyes
(D-AD50)
Robert Rivas
(D-AD29)
Freddie Rodriguez
(D-AD53)
Miguel Santiago
(D-AD54)
Pilar Schiavo
(D-AD40)
Esmeralda Soria
(D-AD27)
Stephanie Nguyen
(D-AD10)
Philip Ting
(D-AD19)
Avelino Valencia
(D-AD68)
Carlos Villapudua
(D-AD13)
Christopher Ward
(D-AD78)
Buffy Wicks
(D-AD14)
Lori Wilson
(D-AD11)
Jim Wood
(D-AD02)
Rick Chavez Zbur
(D-AD51)
Juan Alanis
(R-AD22)
Phillip Chen
(R-AD59)
Laurie Davies
(R-AD74)
Diane Dixon
(R-AD72)
Bill Essayli
(R-AD63)
Heath Flora
(R-AD09)
Josh Hoover
(R-AD07)
Jim Patterson
(R-AD08)
Joe Patterson
(R-AD05)
Tom Lackey
(R-AD34)
Devon Mathis
(R-AD33)
Megan Dahle
(R-AD01)
Kate Sanchez
(R-AD71)
Tri Ta
(R-AD70)
Vince Fong
(R-AD32)
Marie Waldron
(R-AD75)
Greg Wallis
(R-AD47)
Abstain / Other
(5)
Jacqui Irwin
(D-AD42)
Tina McKinnor
(D-AD61)
Akilah Weber Pierson
(D-AD79)
Wendy Carrillo
(D-AD52)
James Gallagher
(R-AD03)
Lobbying activity
FPPC lobbying disclosures whose activity descriptions mention ACR 21, scoped to filings whose coverage period extends through or beyond this bill's introduction date.
Note: CalAccess lobby filings reference bills by measure number only — no session tag. When the same measure number has existed in earlier sessions (e.g. a previously chaptered bill still being lobbied on for implementation), some of those filings may appear here even though they relate to a different bill. Use the activity descriptions to disambiguate.
| Period | Form | Filer | Firm / Employer | Lobbying Activity | Filing |
|---|---|---|---|---|---|
| 07/01/2023–09/30/2023 | Employer Report | CALIFORNIA DIALYSIS COUNCIL | — | AB 85, 101, 236, 365, 503, 564, 614; ACR 21; SB 90, 238, 399, 525, 700, 766; SCA 7 | #2849714 |
| 07/01/2023–09/30/2023 | Employer Report | FRESENIUS MEDICAL CARE NORTH AMERICA AND AFFILIATED ENTITIES | — | AB 85, 101, 236, 365, 503, 564, 614; ACR 21; SB 90, 238, 399, 700, 766; SCA 7; LEGISLATURE, GOVERNOR'S OFFICE RE: HEALTHCARE SERVICES | #2848357 |
| 04/01/2023–06/30/2023 | Employer Report | CALIFORNIA DIALYSIS COUNCIL | — | AB 85, 101, 236, 365, 503, 564, 614; ACR 21; SB 90, 238, 399, 525, 700, 766 | #2831862 |
| 04/01/2023–06/30/2023 | Employer Report | FRESENIUS MEDICAL CARE NORTH AMERICA AND AFFILIATED ENTITIES | — | AB 85, 101, 236, 241, 365, 503, 564, 614; ACR 21; SB 90, 238, 399, 700, 766; SCA 7; LEGISLATURE, GOVERNOR'S OFFICE RE: HEALTHCARE SERVICES | #2831291 |
| 04/01/2023–06/30/2023 | Employer Report | VERTEX PHARMACEUTICALS INC. | — | SCR 49, ACR 21, AB 874, SB 873; Legislature Re: Rare Disease Issues, Sickle Cell Disease Funding, Budget | #2828763 |
| 01/01/2023–03/31/2023 | Employer Report | CALIFORNIA DIALYSIS COUNCIL | — | AB 85, 236, 365, 503, 564; ACR 21; SB 90, 238, 299, 525, 700, 766 | #2808616 |
| 01/01/2023–03/31/2023 | Employer Report | FRESENIUS MEDICAL CARE NORTH AMERICA AND AFFILIATED ENTITIES | — | AB 85, 236, 365, 503, 564; ACR 21; SB 90, 238, 299, 700, 766; LEGISLATURE, GOVERNOR'S OFFICE RE: HEALTHCARE SERVICES | #2809852 |
| 01/01/2023–03/31/2023 | Employer Report | VERTEX PHARMACEUTICALS INC. | — | ACR 21, ACR 23, HR 16, SB 786; Legislature Re: Rare Disease Issues, Sickle Cell Disease Funding | #2808419 |
| Period | Form | Employer | Firm / Filer | Fees | Reimb. | Period Total | Cumulative | Lobbying Activity | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 07/01/2023–09/30/2023 | Firm Activity (payments) | California Dialysis Council | ARNOLD & ASSOCIATES, INC. | $36,000 | $600 | $36,600 | $109,800 | AB 85, AB 101, AB 236, AB 365, AB 503, AB 564, AB 614, ACR 21, SB 90, SB 238, SB 399, SB 525, SB 700, SB 766 SCA 7 | #2846429 |
| 07/01/2023–09/30/2023 | Firm Activity (payments) | Fresenius Medical Care North America and Affiliated Entities | ARNOLD & ASSOCIATES, INC. | $36,000 | $297 | $36,297 | $110,336 | AB 85, AB 101, AB 236, AB 365, AB 503, AB 564, AB 614, ACR21, SB 90, SB 238, SB 399, SB 700, SB 766 SCA 7 | #2846429 |
| 04/01/2023–06/30/2023 | Firm Activity (payments) | California Dialysis Council | ARNOLD & ASSOCIATES, INC. | $36,000 | $600 | $36,600 | $73,200 | AB 85, AB 101, AB 236, AB 365, AB 503, AB 564, AB 614, ACR 21, SB 90, SB 238, SB 399, SB 525, SB 700, SB 766 SCA 7 | #2826834 |
| 04/01/2023–06/30/2023 | Firm Activity (payments) | Fresenius Medical Care North America and Affiliated Entities | ARNOLD & ASSOCIATES, INC. | $36,000 | $1,403 | $37,403 | $74,039 | AB 85, AB 101, AB 236, AB 365, AB 503, AB 564, AB 614, ACR21, SB 90, SB 238, SB 399, SB 700, SB 766 SCA 7 | #2826834 |
| 04/01/2023–06/30/2023 | Firm Activity (payments) | VERTEX PHARMACEUTICALS INCORPORATED | TOPP STRATEGIES | $19,500 | $0 | $19,500 | $31,500 | ACR 21; SCR 49; AB 874; SB 873; LEGISLATURE RE: BUDGET | #2835468 |
| 01/01/2023–03/31/2023 | Firm Activity (payments) | California Dialysis Council | ARNOLD & ASSOCIATES, INC. | $36,000 | $600 | $36,600 | $36,600 | AB85, AB236, AB365, AB503, AB564, ACR21, SB90, SB238, SB299, SB525, SB700, SB766 | #2804065 |
| 01/01/2023–03/31/2023 | Firm Activity (payments) | Fresenius Medical Care North America and Affiliated Entities | ARNOLD & ASSOCIATES, INC. | $36,000 | $636 | $36,636 | $36,636 | AB85, AB236, AB365, AB503, AB564, ACR21, SB90, SB238, SB299, SB700, SB766 | #2804065 |
| 01/01/2023–03/31/2023 | Firm Activity (payments) | VERTEX PHARMACEUTICALS INCORPORATED | TOPP STRATEGIES | $12,000 | — | $12,000 | $12,000 | ACR 21, ACR 23; HR 16; SB 786 | #2811971 |